minjuvi
incyte biosciences distribution b.v. - tafasitamab - lymphoma, large b-cell, diffuse - agents antinéoplasiques - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).
tecvayli
janssen-cilag international n.v. - teclistamab - le myélome multiple - agents antinéoplasiques - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
talvey
janssen-cilag international n.v. - talquetamab - le myélome multiple - agents antinéoplasiques - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
tofranil 50mg comprimé
novartis pharmaceuticals canada inc - chlorhydrate d'imipramine - comprimé - 50mg - chlorhydrate d'imipramine 50mg - tricyclics and other norepinephrine-reuptake inhibitors
tofranil 25mg comprimé
novartis pharmaceuticals canada inc - chlorhydrate d'imipramine - comprimé - 25mg - chlorhydrate d'imipramine 25mg - tricyclics and other norepinephrine-reuptake inhibitors
tofranil 75mg comprimé
novartis pharmaceuticals canada inc - chlorhydrate d'imipramine - comprimé - 75mg - chlorhydrate d'imipramine 75mg - tricyclics and other norepinephrine-reuptake inhibitors
betaloc tab 100 mg comprimé
astrazeneca canada inc - tartrate de métoprolol - comprimé - 100mg - tartrate de métoprolol 100mg - beta-adrenergic blocking agents
betaloc tab 50 mg comprimé
astrazeneca canada inc - tartrate de métoprolol - comprimé - 50mg - tartrate de métoprolol 50mg - beta-adrenergic blocking agents
betaloc durules tab 200 mg comprimé (à libération prolongée)
astrazeneca canada inc - tartrate de métoprolol - comprimé (à libération prolongée) - 200mg - tartrate de métoprolol 200mg - beta-adrenergic blocking agents
betaloc iv inj 1 mg/ml solution
astrazeneca canada inc - tartrate de métoprolol - solution - 1mg - tartrate de métoprolol 1mg - beta-adrenergic blocking agents